Predictors of cardiac survival after percutaneous transluminal coronary angioplasty in patients with severe left...

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Severe left ventricular (LV) dysfunction poses significant risks for patients undergoing cardiac procedures.
• Percutaneous transluminal coronary angioplasty (PTCA) is a common intervention, but outcomes in this high-risk group require careful evaluation.
• Identifying predictors of mortality is crucial for risk stratification and patient management.

Purpose of the Study:

• To evaluate the outcomes of percutaneous transluminal coronary angioplasty (PTCA) in patients with severe left ventricular (LV) dysfunction.
• To identify independent predictors of mortality in this patient cohort following PTCA.

Main Methods:

• Analysis of 73 patients with LV ejection fraction ≤40% who underwent initial PTCA.
• Assessment of baseline characteristics including prior myocardial infarction, congestive heart failure, unstable angina, and multivessel coronary artery disease.
• Follow-up ranging from 6 to 71 months to estimate survival rates.
• Cox regression analysis to determine predictors of mortality.

Main Results:

• Angiographic success was achieved in 85% of attempted lesions.
• Procedure-related mortality was 5%.
• Estimated survival rates at 1, 2, 3, and 4 years were 79%, 74%, 66%, and 57%, respectively.
• Congestive heart failure, lower LV ejection fraction, and higher myocardial jeopardy score were independent predictors of mortality.

Conclusions:

• Percutaneous transluminal coronary angioplasty (PTCA) can be performed in patients with severe left ventricular (LV) dysfunction, but carries a significant risk.
• A subset of high-risk patients can be identified based on clinical factors and cardiac function.
• Predictors of mortality include congestive heart failure, reduced LV ejection fraction, and myocardial jeopardy score, guiding risk stratification.